Introduction: The incidence and prognostic impact of subsequent primary gastric cancer (GC) in a population of other cancer survivors is unclear. We aimed to evaluate susceptibility to subsequent primary GC in cancer survivors and prognosis of GC with prior cancer history. Methods: A total of 2,211 and 23,416 GC cases with and without prior cancer history were retrospectively selected from the Surveillance, Epidemiology, and End Results (SEER) database. Potential risk of developing subsequent primary GC was assessed through standardized incidence ratios (SIRs). Cox regression was adopted to analyze the influence of prior cancer history and clinical characteristic factors on the prognosis of subsequent primary GC. A nomogram was established to predict overall survival (OS). Propensity score matching was conducted to eliminate possible bias. Results: Compared with general population, cancer survivors had an increased risk of subsequent primary GC (SIR 1.17, 95% CI: 1.15–1.20, p < 0.05). Prior cancer history was related to poor OS of GC (adjusted hazard ratio [aHR] 1.12, 95% CI: 1.06–1.19, p < 0.001), but not cancer-specific survival (aHR 0.97, 95% CI: 0.89–1.05, p = 0.441). In addition, age, grade, stage, year of diagnosis, surgery, TNM stage, and tumor size were independent prognostic factors for OS in GC cases with prior cancers. The concordance index of the nomogram was 0.72 (95% CI: 0.71–0.74), and calibrate curves showed good agreement between prediction by the nomogram and actual observation. Conclusions: Cancer survivors with increased risk of developing subsequent primary GC should strengthen their monitoring and follow-up to prevent occurrence of subsequent primary GC.

1.
Maddams
J
,
Brewster
D
,
Gavin
A
,
Steward
J
,
Elliott
J
,
Utley
M
,
.
Cancer prevalence in the United Kingdom: estimates for 2008
.
Br J Cancer
.
2009
;
101
(
3
):
541
7
.
2.
Centers for Disease Control and Prevention
.
Cancer survivorship: United States, 1971–2001
.
MMWR Morb Mortal Wkly Rep
.
2004
;
53
(
24
):
526
9
.
3.
Ueno
M
,
Muto
T
,
Oya
M
,
Ota
H
,
Azekura
K
,
Yamaguchi
T
.
Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer
.
Int J Clin Oncol
.
2003
;
8
(
3
):
162
7
.
4.
Mider
GB
,
Schilling
JA
,
Donovan
JC
,
Rendall
ES
.
Multiple cancer; a study of other cancers arising in patients with primary malignant neoplasms of the stomach, uterus, breast, large intestine, or hematopoietic system
.
Cancer
.
1952
;
5
(
6
):
1104
9
.
5.
Zhou
S
,
Lu
Z
,
Wu
H
,
Gu
CY
,
Zhang
DY
,
Sun
WL
,
.
Synchronous multiple primary gallbladder and gastric malignancies: report of two cases and review of the literature
.
Mol Clin Oncol
.
2017
;
7
(
5
):
869
73
.
6.
Pacheco-Figueiredo
L
,
Antunes
L
,
Bento
MJ
,
Lunet
N
.
Evaluation of the frequency of and survival from second primary cancers in North Portugal: a population-based study
.
Eur J Cancer Prev
.
2013
;
22
(
6
):
599
606
.
7.
Kim
JH
,
Rha
SY
,
Kim
C
,
Kim
GM
,
Yoon
SH
,
Kim
KH
,
.
Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites
.
Cancer Res Treat
.
2010
;
42
(
4
):
217
24
.
8.
Kim
JW
,
Jang
JY
,
Chang
YW
,
Kim
YH
.
Clinical features of second primary cancers arising in early gastric cancer patients after endoscopic resection
.
World J Gastroenterol
.
2015
;
21
(
27
):
8358
65
.
9.
Lawniczak
M
,
Gawin
A
,
Jaroszewicz-Heigelmann
H
,
Rogoza-Mateja
W
,
Raszeja-Wyszomirska
J
,
Bialek
A
,
.
Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study
.
World J Gastroenterol
.
2014
;
20
(
23
):
7480
7
.
10.
Lin
C
,
Wu
J
,
Ding
S
,
Goh
C
,
Andriani
L
,
Shen
K
,
.
Impact of prior cancer history on the clinical outcomes in advanced breast cancer: a propensity score-adjusted, population-based study
.
Cancer Res Treat
.
2020
;
52
(
2
):
552
62
.
11.
Zhou
H
,
Zhang
Y
,
Liu
J
,
Fang
W
,
Yang
Y
,
Hong
S
,
.
Impact of prior cancer on outcomes in nasopharyngeal carcinoma
.
Ann Transl Med
.
2019
;
7
(
14
):
299
.
12.
Kumar
V
,
Ailawadhi
S
,
Bojanini
L
,
Mehta
A
,
Biswas
S
,
Sher
T
,
.
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia
.
Blood Cancer J
.
2019
;
9
(
10
):
75
.
13.
Jamy
O
,
Sarmad
R
,
Costa
L
.
Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors
.
Leuk Res
.
2019
;
82
:
1
6
.
14.
Pujol
JL
,
Molinier
O
,
Ebert
W
,
Daures
JP
,
Barlesi
F
,
Buccheri
G
,
.
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2,063 patients
.
Br J Cancer
.
2004
;
90
(
11
):
2097
105
.
15.
Ganly
I
,
Nixon
IJ
,
Wang
LY
,
Palmer
FL
,
Migliacci
JC
,
Aniss
A
,
.
Survival from differentiated thyroid cancer: what has age got to do with it
.
Thyroid
.
2015
;
25
(
10
):
1106
14
.
16.
Allemani
C
,
Matsuda
T
,
Di Carlo
V
,
Harewood
R
,
Matz
M
,
Niksic
M
,
.
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
.
Lancet
.
2018
;
391
(
10125
):
1023
75
.
17.
Bryant
AK
,
Banegas
MP
,
Martinez
ME
,
Mell
LK
,
Murphy
JD
.
Trends in radiation therapy among cancer survivors in the United States, 2000–2030
.
Cancer Epidemiol Biomarkers Prev
.
2017
;
26
(
6
):
963
70
.
18.
Bray
F
,
Ferlay
J
,
Soerjomataram
I
,
Siegel
RL
,
Torre
LA
,
Jemal
A
.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
.
2018
;
68
(
6
):
394
424
.
19.
Luo
G
,
Zhang
Y
,
Guo
P
,
Wang
L
,
Huang
Y
,
Li
K
.
Global patterns and trends in stomach cancer incidence: age, period and birth cohort analysis
.
Int J Cancer
.
2017
;
141
(
7
):
1333
44
.
20.
GBD 2017 Stomach Cancer Collaborators
.
The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the global burden of disease study 2017
.
Lancet Gastroenterol Hepatol
.
2020
;
5
(
1
):
42
54
.
21.
Chuang
SC
,
Hashibe
M
,
Scelo
G
,
Brewster
DH
,
Pukkala
E
,
Friis
S
,
.
Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries
.
Cancer Epidemiol Biomarkers Prev
.
2008
;
17
(
6
):
1543
9
.
22.
Zhu
G
,
Chen
Y
,
Zhu
Z
,
Lu
L
,
Bi
X
,
Deng
Q
,
.
Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries
.
Dis Esophagus
.
2012
;
25
(
6
):
505
11
.
23.
Ji
J
,
Hemminki
K
.
Second gastric cancers among patients with primary sporadic and familial cancers in Sweden
.
Gut
.
2006
;
55
(
6
):
896
8
.
24.
Mohebbi
M
,
Wolfe
R
,
Jolley
D
,
Forbes
AB
,
Mahmoodi
M
,
Burton
RC
.
The spatial distribution of esophageal and gastric cancer in Caspian region of Iran: an ecological analysis of diet and socio-economic influences
.
Int J Health Geogr
.
2011
;
10
:
13
.
25.
Poon
RT
,
Law
SY
,
Chu
KM
,
Branicki
FJ
,
Wong
J
.
Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications
.
Ann Thorac Surg
.
1998
;
65
(
6
):
1529
34
.
26.
Duma
N
,
Kothadia
SM
,
Azam
TU
,
Yadav
S
,
Paludo
J
,
Vera Aguilera
J
,
.
Characterization of comorbidities limiting the recruitment of patients in early phase clinical trials
.
Oncologist
.
2019
;
24
(
1
):
96
102
.
27.
Klippenstein
P
,
Schlomm
T
,
von Amsberg
G
,
Beyer
B
,
Pompe
RS
,
Michl
U
,
.
Prostate cancer prognosis in men with other malignancies prior to radical prostatectomy
.
Urol Oncol
.
2019
;
37
(
9
):
575 e1
e7
.
28.
Ji
F
,
Yang
CQ
,
Li
XL
,
Zhang
LL
,
Yang
M
,
Li
JQ
,
.
Risk of breast cancer-related death in women with a prior cancer
.
Aging
.
2020
;
12
(
7
):
5894
906
.
29.
Laccetti
AL
,
Pruitt
SL
,
Xuan
L
,
Halm
EA
,
Gerber
DE
.
Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual
.
J Natl Cancer Inst
.
2015
;
107
(
4
):
djv002
.
30.
Smyth
EC
,
Tarazona
N
,
Peckitt
C
,
Armstrong
E
,
Mansukhani
S
,
Cunningham
D
,
.
Exclusion of gastrointestinal cancer patients with prior cancer from clinical trials: is this justified
.
Clin Colorectal Cancer
.
2016
;
15
(
2
):
e53
9
.
31.
Bian
X
,
He
X
,
Yang
L
,
Wu
W
,
Li
L
.
Prognosis of hepatocellular carcinoma among cancer survivors with other types of primary tumors
.
Dig Dis Sci
.
2020
;
65
(
7
):
2140
7
.
32.
Jegu
J
,
Belot
A
,
Borel
C
,
Daubisse-Marliac
L
,
Tretarre
B
,
Ganry
O
,
.
Effect of previous history of cancer on survival of patients with a second cancer of the head and neck
.
Oral Oncol
.
2015
;
51
(
5
):
457
63
.
33.
Andrykowski
MA
.
Physical and mental health status of survivors of multiple cancer diagnoses: findings from the national health interview survey
.
Cancer
.
2012
;
118
(
14
):
3645
53
.
34.
Thong
MS
,
Mols
F
,
Verhoeven
RH
,
Liu
L
,
Andrykowski
MA
,
Roukema
JA
,
.
Multiple primary cancer survivors have poorer health status and well-being than single primary cancer survivors: a study from the population-based PROFILES registry
.
Psychooncology
.
2013
;
22
(
8
):
1834
42
.
35.
Haukoos
JS
,
Lewis
RJ
.
The propensity score
.
JAMA
.
2015
;
314
(
15
):
1637
8
.
You do not currently have access to this content.